These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12422059)
1. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Yeragani VK; Roose S; Mallavarapu M; Radhakrishna RK; Pesce V Neuropsychobiology; 2002; 46(3):125-35. PubMed ID: 12422059 [TBL] [Abstract][Full Text] [Related]
2. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Yeragani VK; Pesce V; Jayaraman A; Roose S Biol Psychiatry; 2002 Sep; 52(5):418-29. PubMed ID: 12242058 [TBL] [Abstract][Full Text] [Related]
3. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712 [TBL] [Abstract][Full Text] [Related]
4. Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder. Yeragani VK; Rao R J Psychosom Res; 2003 Dec; 55(6):507-13. PubMed ID: 14642980 [TBL] [Abstract][Full Text] [Related]
5. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA). Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863 [TBL] [Abstract][Full Text] [Related]
6. A controlled trial of antidepressants in patients with Parkinson disease and depression. Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112 [TBL] [Abstract][Full Text] [Related]
7. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Yeragani VK; Pohl R; Jampala VC; Balon R; Ramesh C; Srinivasan K Depress Anxiety; 2000; 11(3):126-30. PubMed ID: 10875054 [TBL] [Abstract][Full Text] [Related]
8. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram. Bär KJ; Schuhmacher A; Höfels S; Schulz S; Voss A; Yeragani VK; Maier W; Zobel A J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342 [TBL] [Abstract][Full Text] [Related]
10. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Nelson JC; Kennedy JS; Pollock BG; Laghrissi-Thode F; Narayan M; Nobler MS; Robin DW; Gergel I; McCafferty J; Roose S Am J Psychiatry; 1999 Jul; 156(7):1024-8. PubMed ID: 10401446 [TBL] [Abstract][Full Text] [Related]
11. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients. Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly. Bump GM; Mulsant BH; Pollock BG; Mazumdar S; Begley AE; Dew MA; Reynolds CF Depress Anxiety; 2001; 13(1):38-44. PubMed ID: 11233459 [TBL] [Abstract][Full Text] [Related]
13. Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. Dobkin RD; Menza M; Bienfait KL; Gara M; Marin H; Mark MH; Dicke A; Friedman J Am J Geriatr Psychiatry; 2011 Mar; 19(3):222-9. PubMed ID: 20808132 [TBL] [Abstract][Full Text] [Related]
14. Diminished chaos of heart rate time series in patients with major depression. Yeragani VK; Rao KA; Smitha MR; Pohl RB; Balon R; Srinivasan K Biol Psychiatry; 2002 May; 51(9):733-44. PubMed ID: 11983187 [TBL] [Abstract][Full Text] [Related]
15. Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial. Weber E; Stack J; Pollock BG; Mulsant B; Begley A; Mazumdar S; Reynolds CF3rd Am J Geriatr Psychiatry; 2000; 8(3):245-50. PubMed ID: 10910424 [TBL] [Abstract][Full Text] [Related]
16. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Pollock BG; Mulsant BH; Nebes R; Kirshner MA; Begley AE; Mazumdar S; Reynolds CF Am J Psychiatry; 1998 Aug; 155(8):1110-2. PubMed ID: 9699704 [TBL] [Abstract][Full Text] [Related]
17. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil. Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464 [TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637 [TBL] [Abstract][Full Text] [Related]
20. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients. Mamo DC; Pollock BG; Mulsant B; Houck PR; Bensasi S; Miller MC; Redfern MS; Reynolds III CF Am J Geriatr Psychiatry; 2002; 10(2):199-205. PubMed ID: 11925281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]